Clinical Trial Update: Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of cisplatin, etoposide, and cyclophosphamide for extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)

Snippet

Sponsor: Gundersen Lutheran Health System | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED